Sign inJoin waitlistJoin the waitlist

John Chabot

; Chief, GI/Endocrine Surgery Division · New York Presbyterian Hospital

Credentials: · · ·

History

GI/Endocrine Surgery Division · New York Presbyterian Hospital
Present
Division of GI/Endocrine Surgery & Executive Director · New York Presbyterian Hospital
Present
The Pancreas Center · New York Presbyterian Hospital
Present

Dartmouth-Hitchcock Medical Center
1990–1993
Surgery
New York Presbyterian Hospital
1983–1990
Geisel School of Medicine at Dartmouth
1979–1983

Research

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
Cancer Chemotherapy and Pharmacology · 2013 · Last of 15 authors · 194 citations
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Nature · 2024 · 178 citations
Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics
Clinical Cancer Research · 2010 · 175 citations

Beth Schrope
43 papers · 1 as a resident
Michael Kluger
39 papers · 1 as a fellow
John Allendorf
37 papers · 8 as a fellow
MH
Mark Hardy
18 papers
James Lee
16 papers
Jennifer Kuo
15 papers · 2 as a fellow
Gulam Manji
12 papers
Helen Remotti
12 papers
Irene Rossmer
12 papers · 11 as a resident
Alexander Thomas
10 papers · 10 as a resident
RF
Robert Fine
10 papers
RT
Robert Taub
10 papers

Clinical trials

Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
Study chair · Terminated
Columbia University
1999–2004
Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)
Sub-investigator · Unknown · Phase 2, Phase 3
Columbia University
2009